Surrogate outcomes distorting medicine - a podcast by BMJ Group

Surrogate endpoints are commonly used in clinical trials to get quicker results, however Michael Baum, emeritus professor at University College London, worries that by not focusing on real outcomes - length of life, and quality of life - that these are being used to justify expensive treatments which may not benefit patients.

Read the full analysis:

http://www.bmj.com/content/355/bmj.i6286

Further episodes of The BMJ Podcast

Further podcasts by BMJ Group

Website of BMJ Group